Evidence map›Paper›PMID 37766840›Full record

ReviewWorld journal of nephrology2023

Immunoglobulin A vasculitis nephritis: Current understanding of pathogenesis and treatment.

Michela Amatruda, Nicolina Stefania Carucci, Roberto Chimenz, Giovanni Conti

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michela AmatrudaPediatric Nephrology and Rheumatology Unit, AOU G Martino, University of Messina, Messina 98125, Italy.
Nicolina Stefania CarucciPediatric Nephrology and Rheumatology Unit, AOU G Martino, University of Messina, Messina 98125, Italy.
Roberto ChimenzPediatric Nephrology and Rheumatology Unit, AOU G Martino, University of Messina, Messina 98125, Italy.
Giovanni ContiPediatric Nephrology and Rheumatology Unit, AOU G Martino, University of Messina, Messina 98125, Italy. giovanniconti@hotmail.com.
University of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical spectrum of immunoglobulin A vasculitis nephritis (IgAVN) ranges from the relatively common transitory microscopic hematuria and/or low-grade proteinuria to nephritic or nephrotic syndrome, rapidly progressive glomerulonephritis, or even renal failure. Clinical and experimental studies have shown a multifactor pathogenesis: Infection triggers, impaired glycosylation of IgA1, complement activation, Toll-like-receptor activation and B cell proliferation. This knowledge can identify IgAVN patients at a greater risk for adverse outcome and increase the evidence for treatment recommendations.

Indexed as

Henoch-Schoenlein purpuraImmunoglobulin A nephropathyImmunoglobulin A vasculitisImmunoglobulin A vasculitis nephritisVasculitis, glomerulonephritis

Identifiers

PMID37766840
PMCPMC10520755
OpenAlexW4386873710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.